• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
New zealand in vitro diagnostics market outlook to 2018
 

New zealand in vitro diagnostics market outlook to 2018

on

  • 356 views

 

Statistics

Views

Total Views
356
Views on SlideShare
356
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    New zealand in vitro diagnostics market outlook to 2018 New zealand in vitro diagnostics market outlook to 2018 Document Transcript

    • New Zealand In Vitro Diagnostics Market Outlook to2018GlobalData’s new report, “New Zealand In Vitro Diagnostics Market Outlook to 2018 - ClinicalChemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry,Infectious Immunology and Microbiology Culture” provides key market data on the NewZealand In Vitro Diagnostics market. The report provides value (USD million) data for eachsegment and sub-segment within market categories – Clinical Chemistry, Haematology,Immuno Chemistry, Histology And Cytology, Infectious Immunology, Microbiology Culture andGenetic Testing. The report also provides company shares and distribution shares data for eachof the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials andpipeline products, wherever available.Scope- Market size and company share data for In Vitro Diagnostics market categories – ClinicalChemistry, Haematology, Immuno Chemistry, Histology And Cytology, Infectious Immunology,Microbiology Culture and Genetic Testing.- Annualized market revenues (USD million) data for each of the segments and sub-segmentswithin market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the market categories.- Global corporate-level profiles of key companies operating within the New Zealand In VitroDiagnostics market.- Key players covered include Sysmex Corporation, F. Hoffmann-La Roche Ltd., AbbottLaboratories, Beckman Coulter, Inc., Siemens Healthcare, Becton, Dickinson and Company andothers.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the New Zealand In VitroDiagnostics competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.
    • Buy a copy of this report @ http://www.reportsnreports.com/reports/215452-new-zealand-in-vitro-diagnostics-market-outlook-to-2018-clinical-chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-microbiology-culture.htmlReport Details:Published: January 2013No. of Pages: 263Price: Single User License: US$2500 Corporate User License: US$7500Points from Table of Contents :1.1 List of Tables 91.2 List of Figures 132 Introduction 162.1 What is This Report About? 163 In Vitro Diagnostics In New Zealand 173.1 In Vitro Diagnostics, Market Segmentation 173.2 In Vitro Diagnostics, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018 183.3 In Vitro Diagnostics Market, New Zealand, Revenue Mix ($m), 2011 203.4 In Vitro Diagnostics Market, New Zealand, Category Contribution (%), 2011 213.5 In Vitro Diagnostics, New Zealand, Company Share (2010-2011) 284 Clinical Chemistry In New Zealand 304.1 Clinical Chemistry, Market Segmentation 304.2 Clinical Chemistry Market, New Zealand, Revenue Mix ($m), 2011 314.3 Clinical Chemistry Market, New Zealand, Segment Contribution (%), 2011 324.4 Clinical Chemistry Overall Revenue, (2004-2018) 334.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 374.4.2 Urine Analysis, Revenue (2004-2018) 414.5 Clinical Chemistry Distribution Share (2010-2011) 454.6 Clinical Chemistry, New Zealand, Company Share (2010-2011) 465 Genetic Testing In New Zealand 485.1 Genetic Testing, Market Segmentation 485.2 Genetic Testing Market, New Zealand, Revenue Mix ($m), 2011 495.3 Genetic Testing Market, New Zealand, Segment Contribution (%), 2011 50
    • 5.4 Genetic Testing Overall Revenue, (2004-2018) 515.5 Genetic Testing Distribution Share (2010-2011) 555.6 Genetic Testing, New Zealand, Company Share (2010-2011) 566 Haematology In New Zealand 586.1 Haematology Market, Market Segmentation 586.2 Haematology Market, New Zealand, Revenue Mix ($m), 2011 596.3 Haematology Market, New Zealand, Segment Contribution (%), 2011 606.4 Haematology Overall Revenue, (2004-2018) 616.4.1 Haematology Reagents, Revenue (2004-2018) 656.4.2 Immunohaematology, Revenue (2004-2018) 696.4.3 Haemostasis, Revenue (2004-2018) 736.4.4 Haematology Rapid Tests, Revenue (2004-2018) 776.4.5 Haematology Cell Counters, Revenue (2004-2018) 816.5 Haematology Distribution Share (2010-2011) 856.6 Haematology, New Zealand, Company Share (2010-2011) 867 Histology And Cytology In New Zealand 887.1 Histology And Cytology Market, Market Segmentation 887.2 Histology And Cytology Market, New Zealand, Revenue Mix ($m), 2011 897.3 Histology And Cytology Market, New Zealand, Segment Contribution (%), 2011 907.4 Histology And Cytology Overall Revenue, (2004-2018) 917.5 Histology And Cytology Distribution Share (2010-2011) 957.6 Histology And Cytology, New Zealand, Company Share (2010-2011) 968 Immuno Chemistry In New Zealand 988.1 Immuno Chemistry Market, New Zealand, Revenue Mix ($m), 2011 988.2 Immuno Chemistry Market, New Zealand, Segment Contribution (%), 2011 998.3 Immuno Chemistry Overall Revenue, (2004-2018) 1008.3.1 Disease Specific Immunochemistry, Revenue, (2004-2018) 1048.3.2 Drugs of Abuse / Toxicology, Revenue, (2004-2018) 1088.3.3 Endocrinology Tests, Revenue, (2004-2018) 1128.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 1168.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 1208.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 1248.4 Immuno Chemistry Distribution Share (2010-2011) 1288.5 Immuno Chemistry, New Zealand, Company Share (2010-2011) 1299 Infectious Immunology In New Zealand 1319.1 Infectious Immunology, Market Segmentation 1319.2 Infectious Immunology Market, New Zealand, Revenue Mix ($m), 2011 132
    • 9.3 Infectious Immunology Market, New Zealand, Segment Contribution (%), 2011 1339.4 Infectious Immunology Overall Revenue, (2004-2018) 1349.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 1389.5 Infectious Immunology Distribution Share (2010-2011) 1429.6 Infectious Immunology, New Zealand, Company Share (2010-2011) 14310 Microbiology Culture In New Zealand 14510.1 Microbiology Culture, Market Segmentation 14510.2 Microbiology Culture Market, New Zealand, Revenue Mix ($m), 2011 14610.3 Microbiology Culture Market, New Zealand, Segment Contribution (%), 2011 14710.4 Microbiology Culture Overall Revenue, (2004-2018) 14810.4.1 Microbiology Analyzers, Revenue (2004-2018) 15210.5 Microbiology Culture Distribution Share (2010-2011) 15610.6 Microbiology Culture, New Zealand, Company Share (2010-2011) 15711 Overview of Key Companies in New Zealand In Vitro Diagnostics Market 15911.1 Sysmex Corporation 15911.1.1 Company Overview 15911.1.2 Share in the New Zealand In Vitro Diagnostics Market 15911.2 F. Hoffmann-La Roche Ltd. 16011.2.1 Company Overview 16011.2.2 Share in the New Zealand In Vitro Diagnostics Market 16011.3 Abbott Laboratories 16111.3.1 Company Overview 16111.3.2 Share in the New Zealand In Vitro Diagnostics Market 16111.4 Beckman Coulter, Inc. 16211.4.1 Company Overview 16211.4.2 Share in the New Zealand In Vitro Diagnostics Market 16211.5 Siemens Healthcare 16311.5.1 Company Overview 16311.5.2 Share in the New Zealand In Vitro Diagnostics Market 16311.6 Becton, Dickinson and Company 16411.6.1 Company Overview 16411.6.2 Share in the New Zealand In Vitro Diagnostics Market 16411.7 Ortho-Clinical Diagnostics Inc. 16511.7.1 Company Overview 16511.8 bioMerieux S.A. 16511.8.1 Company Overview 16511.9 Bio-Rad Laboratories, Inc. 166
    • 11.9.1 Company Overview 16611.10 Alere Inc. 16611.10.1 Company Overview 16611.11 Qiagen N.V. 16711.11.1 Company Overview 16711.12 Life Technologies Corporation 16711.12.1 Company Overview 16711.13 DiaSorin S.p.A 16811.13.1 Company Overview 16811.14 Horiba, Ltd. 16811.14.1 Company Overview 16811.15 Danaher Corporation 16911.15.1 Company Overview 16911.16 Mindray Medical International Limited 16911.16.1 Company Overview 16911.17 Grifols, S.A. 17011.17.1 Company Overview 17011.18 PerkinElmer, Inc. 17011.18.1 Company Overview 17011.19 Thermo Fisher Scientific Inc. 17111.19.1 Company Overview 17111.20 Gen-Probe Incorporated 17111.20.1 Company Overview 17111.21 Diagnostica Stago, Inc. 17211.21.1 Company Overview 17211.22 Phadia AB 17211.22.1 Company Overview 17212 In Vitro Diagnostics Market Pipeline Products 17312.1 Clinical Chemisty Market Pipeline Products 17312.2 Immuno Chemistry Market Pipeline Products 17612.3 Haematology Market Pipeline Products 18712.4 Infectious Immunology Market Pipeline Products 18912.5 Microbiology Culture Market Pipeline Products 19612.6 Histology And Cytology Market Pipeline Products 19712.7 Genetic Testing Market Pipeline Products 19813 Financial Deals Landscape 20313.1 Partnerships 203
    • 13.1.1 Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs ForTranscreener Epigen Methyltransferase Assay 20313.1.2 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 20513.1.3 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments ForArchimedes Particle Metrology System 20713.1.4 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 20813.1.5 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New OncologyAssays 20913.1.6 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For DigitalMicroscopy Hematology Solutions 21013.1.7 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpressDx Test 21213.1.8 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology21413.1.9 CML HealthCare Enters Into Agreement With MaRS Innovation 21513.1.10 Akrivis Technologies Enters Into Co-Development Agreement With United StatesBiological 21613.1.11 Castle Biosciences Enters Into Licensing Agreement With Brigham and WomensHospital For Mesothelioma Test 21713.1.12 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For ProteinArray Products 21813.1.13 GeneCentric Diagnostics Enters Into Licensing Agreement With University of NorthCarolina 21913.1.14 Epistem Enters Into Distribution Agreement With Becton Dickinson For MycobacteriumTB Test 22013.1.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich ForPhenoFluor 22113.1.16 Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems22213.1.17 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 22313.1.18 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test22413.1.19 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus22613.1.20 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 22813.1.21 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POCTest 230
    • 13.1.22 One Lambda Enters Into Co-Marketing Agreement With CellTrend 23113.1.23 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics ForALK Cancer Biomarker 23213.1.24 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 23313.1.25 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERGMarker 23413.1.26 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating TumorCell Technology 23513.1.27 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 23613.1.28 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRangePCR Kit 23713.1.29 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 23813.1.30 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery ForPressure Cycling Technology 23913.1.31 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 24113.1.32 GE Healthcare Enters Into Co-Development Agreement With NXT2B For CompactCyclotron And PET Tracer System 24213.1.33 Sysmex Extends Distribution Agreement With Roche 24313.1.34 NexDx Enters Into Licensing Agreement With University of California For EpigeneticBiomarkers 24513.1.35 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 24613.1.36 ZyGEM Enters Into Co-Development Agreement With USAMRIID 24714 Appendix 24814.1 Definitions of Markets Covered in the Report 24914.1.1 In Vitro Diagnostics 24914.2 Research Methodology 26014.3 Secondary Research 26014.4 Primary Research 26114.5 Models 26114.8 GlobalData Consulting 26214.9 Currency Conversion 26314.10 Contact Us 26314.11 Disclaimer 263Contact sales@reportsandreports.com for more details.